Eli Lilly & Co., Pfizer Inc. and Johnson & Johnson secured spots on China’s first innovative drug catalog, opening a new ...
As China's aging population increases demand for therapies treating everything from cancer and diabetes to dementia, the ...
Pfizer stock offers 30% upside with strong non-COVID franchises, margin expansion, and pipeline potential. Click here to read ...
New York City office buildings that were originally used by firms such as Goldman Sachs are being transformed into luxury ...
Pfizer (PFE), and Johnson & Johnson (JNJ) secured spots on China's first innovative drug catalog for private insurance, ...
The burgeoning field of transthyretin amyloid cardiomyopathy (ATTR-CM), which spurred excitement over a potential $20 billion ...
(Bloomberg) -- New York developers are transforming struggling office buildings into more than 12,000 new apartments in a bid ...
4d
Beghou Adds New Partners to Advance Integrated, Experience-Driven Commercialization in Life Sciences
Beghou today announced that seasoned industry leaders Jenny Herritz and Marcos Mendell have joined as partners. This reflects Beghou’s commitment to hiring top talent and its focus on helping life ...
Three years after introducing Hemgenix, the first gene therapy for hemophilia B, CSL Behring has released long-term data ...
Preliminary clinical evidence of Lisaftoclax overcoming venetoclax resistance in myeloid malignancies with a 31.8% overall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback